Mechanism: High-amplitude circadian rhythms drive NAD+ production, fueling SIRT1 and PARP1 for efficient DNA repair, which slows epigenetic aging. Readout: Readout: Timed NAD+ precursor supplementation in aged cells restores NAD+ peaks, boosts PARP1 activity, and reduces epigenetic age acceleration.
Hypothesis
Circadian amplitude directly gates NAD+-dependent DNA repair, setting the pace of epigenetic aging. High-amplitude BMAL1/CLOCK drives rhythmic NAMPT expression, producing NAD+ peaks that synchronize SIRT1 deacetylase and PARP1 polymerase activity with the cell’s repair windows. When amplitude declines, NAD+ troughs widen, PARP1 falters, and unrepaired DNA lesions accelerate epigenetic drift, independently of transcriptional noise.
Mechanistic Insight
The core clock does more than regulate transcription; it sculpts the metabolic landscape that fuels genome maintenance. BMAL1 binds the NAMPT promoter, creating a circadian NAD+ surge that coincides with the early active phase. NAD+ fuels SIRT1, which deacetylates histones and repair factors, while PARP1 consumes NAD+ to detect strand breaks. Thus, the clock’s amplitude determines the NAD+ reserve available for PARP1 during genotoxic stress. Low amplitude leaves cells chronically NAD+-deficient, impairing PARP1-mediated repair and promoting epigenetic aging.
Testable Predictions
- Prediction 1: In young mice, NAD+ levels will show a robust (~2‑fold) daily rhythm matching BMAL1 binding to the NAMPT promoter; in aged mice, this rhythm will flatten and PARP1 activity after oxidative challenge will be reduced proportionally.
- Prediction 2: Administering an NAD+ precursor (e.g., nicotinamide riboside) at the circadian peak (ZT4) will restore NAD+ amplitude, boost PARP1 activity, and slow the epigenetic clock (measured by DNA‑methylation age) more effectively than the same dose given at the trough (ZT16).
- Prediction 3: Genetic disruption of BMAL1 in liver will abolish NAD+ rhythms, increase epigenetic age acceleration, and this phenotype will be rescued by timed NAD+ supplementation but not by constant‑level NAD+ infusion.
Falsifiability
If timed NAD+ supplementation fails to improve PARP1 activity or epigenetic age regardless of administration phase, or if NAD+ rhythms do not correlate with PARP1‑mediated repair across ages, the hypothesis is falsified.
Supporting Citations
- BMAL1/CLOCK regulation of SIRT1 and aging pathways [1]
- BMAL1 deficiency causing premature aging and oxidative stress [2]
- High‑amplitude rhythms correlating with longevity and age‑related dampening driving damage [3]
- Clock knockout shortening lifespan and accelerating muscle mitochondrial impairment [4]
- Period gene overexpression extending Drosophila healthspan under oxidative stress [5]
- Time‑restricted feeding sustaining rhythms and preventing metabolic disease [6]
Comments
Sign in to comment.